Sign In
Buy PGNY
$26.28
+0.200 (+0.767%)
At Close: Jun 22, 2026
Progyny, Inc. (PGNY) Hits Fresh High: Is There Still Room to Run?
10:16am, Tuesday, 23'rd Dec 2025
Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Progyny (PGNY) Upgraded to Buy: Here's What You Should Know
01:01pm, Monday, 15'th Dec 2025
Progyny (PGNY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Edgestream Partners L.P. Boosts Stake in Progyny, Inc. $PGNY
04:27am, Thursday, 04'th Dec 2025
Edgestream Partners L.P. increased its holdings in shares of Progyny, Inc. (NASDAQ: PGNY) by 99.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange C
CEO Peter Anevski Buys $1.9 Million of Progyny Stock: Should Investors Buy Too?
06:16pm, Tuesday, 02'nd Dec 2025
CEO Anevski now owns $17 million worth of Progyny. Progyny's stock popped roughly 8% the day of the announcement.
Is Progyny (PGNY) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:46pm, Monday, 24'th Nov 2025
Progyny (PGNY) possesses solid growth attributes, which could help it handily outperform the market.
New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action
09:23am, Thursday, 20'th Nov 2025
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in family building solutions, today announced new men's health research exploring experiences and views on fer
Progyny: Growth Has Returned (Rating Upgrade)
08:45am, Wednesday, 19'th Nov 2025
Progyny (PGNY) surges after strong Q3 earnings, robust client growth, and a $200M share buyback, signaling renewed momentum and market confidence. PGNY overcame Amazon's departure by adding new client
Does Progyny Stock Lead The Pack?
11:10am, Tuesday, 18'th Nov 2025
Progyny is a leader in fertility benefits, offering employers comprehensive, outcomes-based solutions that improve treatment success and manage costs. Its focused model has driven strong demand and se
Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue?
10:16am, Tuesday, 18'th Nov 2025
Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PGNY vs. HQY: Which Stock Is the Better Value Option?
12:40pm, Friday, 14'th Nov 2025
Investors interested in stocks from the Medical Services sector have probably already heard of Progyny (PGNY) and HealthEquity (HQY). But which of these two stocks is more attractive to value investor
Aviva PLC Has $477,000 Holdings in Progyny, Inc. $PGNY
04:05am, Friday, 14'th Nov 2025
Aviva PLC trimmed its holdings in shares of Progyny, Inc. (NASDAQ: PGNY) by 23.7% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC
Progyny, Inc. to Present at Jefferies Global Healthcare Conference
12:33pm, Thursday, 13'th Nov 2025
NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that Mark Livingston, Progyny's Chief Financi
Why Progyny Stock Is Soaring Today
01:02pm, Friday, 07'th Nov 2025
Progyny's third-quarter results were exceptional. Sales grew by 9% and were up by 23% on an adjusted basis, accounting for the loss of a major customer last year.
Progyny, Inc. (PGNY) Q3 2025 Earnings Call Transcript
07:26pm, Thursday, 06'th Nov 2025
Progyny, Inc. ( PGNY ) Q3 2025 Earnings Call November 6, 2025 4:45 PM EST Company Participants James Hart - Vice President of Investor Relations Peter Anevski - CEO & Director Mark Livingston - Chief
Progyny (PGNY) Q3 Earnings and Revenues Beat Estimates
06:21pm, Thursday, 06'th Nov 2025
Progyny (PGNY) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.4 per share a year ago.
